產品詳情
簡單介紹：
Anti-EPLIN抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-EPLIN抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-EPLIN
Cat. Number:
Anti-EPLIN抗體KL-13086R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Epithelial protein lost in neoplasm (EPLIN) is a cytoskeleton-associated protein characterized by the presence of a single centrally located lin-11, isl-1 and mec-3 (LIM) domain. It also contains at least two Actin-binding domains, in which Anti-EPLIN抗體the C-terminal domain binds more effectively than the N-terminal domain. By binding Actin monomers and filaments, EPLIN is involved in regulation of the Actin cytoskeleton by increasing the number and size of Actin stress fibers, delaying filament nucleation, reducing formation of branched filaments and bundling of Actin filaments. It also inhibits membrane ruffling and Actin filament depolymerization. EPLIN is strongly expressed in placenta, kidney, pancreas, prostate, ovary, spleen and heart, and to a lesser degree in lung, liver, brain, skeletal muscle, thymus, testis and intestine. It is expressed as two isoforms, EPLIN-α and EPLIN-β. Downregulation of EPLIN-α expression may contribute to the motility of invasive tumor cells.
Also known as:
1110021C24Rik; Epithelial protein lost in neoplasm; Epithelial protein lost in neoplasm beta; EPLIN; FLJ38853; LIM domain and actin binding 1; Anti-EPLIN抗體LIM domain and actin binding protein 1; LIM domain and actin-binding protein 1; LIMA1; LIMA1_HUMAN; MGC131726; SREBP3; Sterol regulatory element binding protein 3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Dog, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EPLIN.
●
Predicted Molecular Weight:Anti-EPLIN抗體 85kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-EPLIN抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EPLIN抗體
Optimal working dilutions must be determined by the end user.
kl930Hu01 細胞外信號調節激酶2(ERK2)多克隆抗體 Polyclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2)
kl933Hu01 內凝集蛋白1(ITLN1)多克隆抗體 Polyclonal Antibody to Intelectin 1 (ITLN1)
kl933Mu01 內凝集蛋白1(ITLN1)多克隆抗體 Polyclonal Antibody to Intelectin 1 (ITLN1)
kl933Ra01 內凝集蛋白1(ITLN1)多克隆抗體 Polyclonal Antibody to Intelectin 1 (ITLN1)
kl934Hu01 過氧化物酶體增殖物激活受體α(Pklα)多克隆抗體 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Alpha (Pkla)
kl934Mu01 過氧化物酶體增殖物激活受體α(Pklα)多克隆抗體 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Alpha (Pkla)
kl936Hu01 磷酸烯醇式丙酮酸羧激酶1(PCK1)多克隆抗體 Polyclonal Antibody to Phosphoenolpyruvate Carboxykinase 1, Soluble (PCK1)
kl936Mu01 磷酸烯醇式丙酮酸羧激酶1(PCK1)多克隆抗體 Polyclonal Antibody to Phosphoenolpyruvate Carboxykinase 1, Soluble (PCK1)
kl937Hu01 腎足蛋白(NPHN)多克隆抗體 Polyclonal Antibody to Nephrin (NPHN)
kl937Mu01 腎足蛋白(NPHN)多克隆抗體 Polyclonal Antibody to Nephrin (NPHN)
kl937Ra01 腎足蛋白(NPHN)多克隆抗體 Polyclonal Antibody to Nephrin (NPHN)
kl938Hu01 足突蛋白(PDCN)多克隆抗體 Polyclonal Antibody to Podocin (PDCN)
kl938Ra01 足突蛋白(PDCN)多克隆抗體 Polyclonal Antibody to Podocin (PDCN)
kl940Hu01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl940Mu01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl940Po01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl944Hu01 巖藻糖基轉移酶3(FUT3)多克隆抗體 Polyclonal Antibody to Fucosyltransferase 3 (FUT3)
